<DOC>
	<DOCNO>NCT01016847</DOCNO>
	<brief_summary>Obesity associate increase airway inflammation asthma severity result suboptimal control asthma despite therapy high dose inhale corticosteroid ( ICS ) . The investigator suggest addition Singular ( montelukast ) [ LTRA ] moderate dos inhale corticosteroid improve asthma control . This cross study treat subject moderate dose ICS/LTRA 12 week high dose ICS placebo 12 week .</brief_summary>
	<brief_title>Moderate Persistent Asthma Obese Subject</brief_title>
	<detailed_description>Subjects enter 2-week run-in period meeting eligibility criterion screen visit ( visit 1 ) . During run-in subject usual asthma medication discontinue place inhaled corticosteroid moderate dos leukotriene receptor antagonist withdraw ( LTRA wash-out ) . Subjects monitor rule acute infection symptom consistent exacerbation . The run-in period use ass subject compliance understanding study related procedure . Following run-in , eligible randomization subject must ACQ score &gt; 1.25 Juniper Asthma Control Questionnaire .</detailed_description>
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Beclomethasone</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>moderate persistent asthma define daily symptom , nocturnal awakening &gt; 1 time/week daily , daily shortacting beta agonist usage prebronchodilator Force expiratory volume ( FEV1 ) &gt; 55 % &lt; 90 % . Subjects must controller therapy asthma ICS least one month prior enrollment . methacholine test cause drop FEV1 20 % ( 8mg/ml ICS 16mg/ml ) ICS within 6 month prior entry physician diagnosis asthma least one year prior study enrollment . Obesity define BMI great 30. subject must Asthma Control Questionnaire ( ACQ ) score &gt; 1.25 Juniper Asthma Control Questionnaire ( indicate poor asthma control ) , require daily medication asthma compliant study related medication . Subjects must intubate last 5 year unstable asthma symptom result significant loss work school upper low respiratory tract infection within 1 month study use antibiotic within 4 week study use oral glucocorticoid within 4 week use theophylline smoking history great 10 pack year cigarette use within past two year significant nonasthma pulmonary disease medical problem Subjects plan undergo gastric bypass surgery within 4 month enrollment date exclude since weight loss potential confounder asthma control Pregnant woman also exclude</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
</DOC>